Goldman Sachs Group Inc. acquired a new position in shares of IRIDEX Corporation (NASDAQ:IRIX) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 61,416 shares of the medical equipment provider’s stock, valued at approximately $607,000. Goldman Sachs Group Inc. owned about 0.53% of IRIDEX Corporation as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. LMR Partners LLP purchased a new stake in IRIDEX Corporation during the 2nd quarter worth approximately $242,000. Isthmus Partners LLC increased its holdings in IRIDEX Corporation by 55.8% during the 2nd quarter. Isthmus Partners LLC now owns 73,263 shares of the medical equipment provider’s stock worth $725,000 after purchasing an additional 26,228 shares during the last quarter. First Light Asset Management LLC purchased a new stake in IRIDEX Corporation during the 2nd quarter worth approximately $997,000. Renaissance Technologies LLC increased its holdings in IRIDEX Corporation by 2.2% during the 1st quarter. Renaissance Technologies LLC now owns 200,304 shares of the medical equipment provider’s stock worth $2,378,000 after purchasing an additional 4,404 shares during the last quarter. Finally, Vanguard Group Inc. increased its holdings in IRIDEX Corporation by 0.4% during the 2nd quarter. Vanguard Group Inc. now owns 392,317 shares of the medical equipment provider’s stock worth $3,880,000 after purchasing an additional 1,731 shares during the last quarter. Institutional investors own 48.24% of the company’s stock.

Several research firms have issued reports on IRIX. Zacks Investment Research upgraded IRIDEX Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, October 4th. Roth Capital restated a “buy” rating and set a $13.00 price objective on shares of IRIDEX Corporation in a report on Friday, November 3rd.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/11/12/61416-shares-in-iridex-corporation-irix-acquired-by-goldman-sachs-group-inc.html.

Shares of IRIDEX Corporation (IRIX) opened at $8.12 on Friday. IRIDEX Corporation has a twelve month low of $7.58 and a twelve month high of $16.39.

IRIDEX Corporation Profile

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD).

Want to see what other hedge funds are holding IRIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IRIDEX Corporation (NASDAQ:IRIX).

Institutional Ownership by Quarter for IRIDEX Corporation (NASDAQ:IRIX)

Receive News & Ratings for IRIDEX Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX Corporation and related companies with MarketBeat.com's FREE daily email newsletter.